Table 5.

Effect modification by age

SNP	Noncarriers		Carriers		P*
SNP	Case/control	OR	Case/control	OR (95% CI)	P*
SNP1
Age ≤65	132/171	1.00	169/139	1.47 (1.09-2.00)	0.22
Age >65	187/203	1.00	185/167	1.20 (0.91-1.58)	0.22
SNP2
Age ≤65	127/121	1.00	184/194	0.92 (0.68-1.24)	0.48
Age >65	146/149	1.00	239/231	1.04 (0.79-1.37)	0.48
SNP3
Age ≤65	146/132	1.00	163/180	0.84 (0.63-1.14)	0.27
Age >65	162/163	1.00	218/210	1.04 (0.79-1.37)	0.27
SNP4
Age ≤65	193/157	1.00	118/157	0.64 (0.47-0.86)	0.01
Age >65	200/203	1.00	184/177	1.02 (0.78-1.35)	0.01
SNP5
Age ≤65	146/132	1.00	151/173	0.79 (0.59-1.07)	0.18
Age >65	151/158	1.00	210/206	1.00 (0.76-1.31)	0.18
SNP6
Age ≤65	227/210	1.00	73/100	0.67 (0.47-0.94)	0.53
Age >65	284/262	1.00	93/109	0.79 (0.57-1.09)	0.53
SNP7
Age ≤65	190/152	1.00	120/161	0.63 (0.46-0.85)	0.01
Age >65	198/200	1.00	186/176	1.05 (0.80-1.39)	0.01
SNP9
Age ≤65	250/230	1.00	51/79	0.59 (0.40-0.87)	0.41
Age >65	299/281	1.00	70/89	0.72 (0.51-1.03)	0.41
SNP10
Age ≤65	153/138	1.00	144/170	0.76 (0.56-1.02)	0.17
Age >65	167/167	1.00	203/196	1.03 (0.78-1.35)	0.17
SNP11
Age ≤65	258/281	1.00	37/24	1.61 (0.94-2.74)	0.04
Age >65	330/324	1.00	32/40	0.78 (0.48-1.27)	0.04
SNP12
Age ≤65	236/233	1.00	73/80	0.91 (0.63-1.29)	0.40
Age ≤65	279/280	1.00	104/94	1.12 (0.81-1.54)	0.40
SNP13
Age ≤65	222/205	1.00	73/101	0.66 (0.47-0.94)	0.03
Age >65	253/254	1.00	121/109	1.13 (0.83-1.53)	0.03
SNP14
Age ≤65	227/208	1.00	73/101	0.66 (0.46-0.93)	0.06
Age >65	253/258	1.00	116/114	1.00 (0.73-1.35)	0.06
SNP15
Age ≤65	278/273	1.00	21/34	0.60 (0.34-1.06)	0.09
Age >65	318/333	1.00	37/33	1.12 (0.69-1.82)	0.09
SNP16
Age ≤65	232/211	1.00	56/86	0.59 (0.41-0.86)	0.02
Age >65	255/267	1.00	95/90	1.05 (0.76-1.45)	0.02